A therapeutic opportunity that needs to be optimized.
Oscar M P
OM
Jolobe
D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001024:Aortic Valve Stenosis / Q000150:complications*; D058070:Asymptomatic Diseases / Q000628:therapy*; D001281:Atrial Fibrillation / Q000209:etiology / Q000517:prevention & control*; D000077545:Eplerenone; D006352:Heart Ventricles / Q000473:pathology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D013148:Spironolactone; D000077545:Eplerenone